The Effect of Antioxidants on Skin Blood Flow-BH4

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

May 5, 2018

Study Completion Date

May 5, 2018

Conditions
Cardiovascular DiseasesCardiovascular Risk FactorVasoconstriction
Interventions
DRUG

Control: Lacated Ringers

This site will serve as the control site

DRUG

Apocynin

This site will be used to inhibit NADPH oxidase and subsequent production of superoxide.

DRUG

Allopurinol

This site will be use to inhibit xanthine oxidase and subsequent production of superoxide.

DRUG

BH4

This site will be use to locally supplement BH4.

DRUG

NG Nitro L Arginine Methyl Ester

L-Name is a NOS inhibitor that is administered to each site to allow for the quantification of NO contribution to vasodilation. The infusion rate will be 2 µl/min

DRUG

Sodium Nitroprusside

SNP will be perfused through each site to induce maximal vasodilation. The infusion rate will be 2 µl/min

DRUG

Acetyl-ß-methylcholine chloride

Mch is an acetylcholine analog that causes endothelial dependent vasodilation primarily through stimulation of NO production.

Trial Locations (1)

76019

Engineering Research Building, Arlington

All Listed Sponsors
lead

The University of Texas at Arlington

OTHER

NCT03680573 - The Effect of Antioxidants on Skin Blood Flow-BH4 | Biotech Hunter | Biotech Hunter